Dynamics of MDS-PA and clonal hematopoiesis before and after autologous transplant. (A) Longitudinal screening of MDS-PA in 84 patients at diagnosis and at day 100 after HDT/ASCT. (B) Distribution of patients (n = 18) according to the detection of mutations in both time points. VRD, bortezomib, lenalidomide, and dexamethasone.